Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 07-Dec-21 9:10 PM View:  | Emergent BioSolutions, Inc. (EBS) | 03-Dec-21 | Acquisition (other) | 3,500,010 | -- | -- | 308% 1.14M to 4.64M | |
| 07-Dec-21 9:09 PM View: | Aptevo Therapeutics Inc. (APVO) | 03-Dec-21 | Acquisition (other) | 124,999 | -- | -- | 156% 80.32K to 205.32K | |
| 12-Nov-20 6:30 PM View: | Emergent BioSolutions, Inc. (EBS) | 10-Nov-20 | Option Exercise | 19,391 | $26.45 | $512,892.00 | < 1% 4.79M to 4.81M | |
| 12-Nov-20 6:30 PM View: | Emergent BioSolutions, Inc. (EBS) | 10-Nov-20 | Market Option Sale (Planned) | 19,391 | $88.21 | $1,710,480.00 | (< 1%) 4.81M to 4.79M | (8%) |
| 12-Nov-20 6:30 PM View: | Emergent BioSolutions, Inc. (EBS) | 09-Nov-20 | Option Exercise | 20,000 | $26.45 | $529,000.00 | < 1% 4.79M to 4.81M | |
| 12-Nov-20 6:30 PM View: | Emergent BioSolutions, Inc. (EBS) | 09-Nov-20 | Market Option Sale (Planned) | 20,000 | $95.26 | $1,905,200.00 | (< 1%) 4.81M to 4.79M | < 1% |
| 04-Nov-20 8:53 PM View: | Emergent BioSolutions, Inc. (EBS) | 03-Nov-20 | Option Exercise | 20,000 | $26.45 | $529,000.00 | < 1% 4.79M to 4.81M | |
| 04-Nov-20 8:53 PM View: | Emergent BioSolutions, Inc. (EBS) | 03-Nov-20 | Market Option Sale (Planned) | 20,000 | $90.74 | $1,814,800.00 | (< 1%) 4.81M to 4.79M | (5%) |
| 04-Nov-20 8:53 PM View: | Emergent BioSolutions, Inc. (EBS) | 02-Nov-20 | Option Exercise | 20,000 | $26.45 | $529,000.00 | < 1% 4.79M to 4.81M | |
| 04-Nov-20 8:53 PM View: | Emergent BioSolutions, Inc. (EBS) | 02-Nov-20 | Market Option Sale (Planned) | 20,000 | $90.44 | $1,808,800.00 | (< 1%) 4.81M to 4.79M | (5%) |
| 25-Sep-20 7:00 PM View: | Emergent BioSolutions, Inc. (EBS) | 24-Sep-20 | Market Sale (Planned) | 12,535 | $98.85 | $1,239,080.00 | (< 1%) 4.8M to 4.79M | 4% |
| 25-Sep-20 7:00 PM View: | Emergent BioSolutions, Inc. (EBS) | 23-Sep-20 | Market Sale (Planned) | 13,000 | $100.58 | $1,307,540.00 | (< 1%) 4.81M to 4.8M | 5% |
| 18-Sep-20 6:25 PM View: | Emergent BioSolutions, Inc. (EBS) | 17-Sep-20 | Market Sale (Planned) | 20,000 | $100.68 | $2,013,600.00 | (< 1%) 4.83M to 4.81M | 6% |
| 18-Sep-20 6:25 PM View: | Emergent BioSolutions, Inc. (EBS) | 16-Sep-20 | Market Sale (Planned) | 20,000 | $102.48 | $2,049,600.00 | (< 1%) 4.85M to 4.83M | 7% |
| 11-Sep-20 9:21 PM View: | Emergent BioSolutions, Inc. (EBS) | 10-Sep-20 | Market Sale (Planned) | 20,000 | $102.66 | $2,053,200.00 | (< 1%) 4.87M to 4.85M | 7% |
| 11-Sep-20 9:21 PM View: | Emergent BioSolutions, Inc. (EBS) | 09-Sep-20 | Market Sale (Planned) | 20,000 | $102.80 | $2,056,000.00 | (< 1%) 4.89M to 4.87M | 8% |
| 01-May-20 8:13 PM View: | Emergent BioSolutions, Inc. (EBS) | 30-Apr-20 | Market Sale (Planned) | 20,000 | $74.01 | $1,480,200.00 | (< 1%) 7.12M to 7.1M | (28%) |
| 01-May-20 8:13 PM View: | Emergent BioSolutions, Inc. (EBS) | 29-Apr-20 | Market Sale (Planned) | 20,000 | $74.24 | $1,484,800.00 | (< 1%) 7.14M to 7.12M | (28%) |
| 24-Apr-20 4:16 PM View: | Emergent BioSolutions, Inc. (EBS) | 23-Apr-20 | Market Sale (Planned) | 20,000 | $68.49 | $1,369,800.00 | (< 1%) 7.16M to 7.14M | (39%) |
| 24-Apr-20 4:16 PM View: | Emergent BioSolutions, Inc. (EBS) | 22-Apr-20 | Market Sale (Planned) | 20,000 | $66.81 | $1,336,200.00 | (< 1%) 7.18M to 7.16M | (42%) |
| 20-Apr-20 6:30 PM View: | Emergent BioSolutions, Inc. (EBS) | 16-Apr-20 | Market Sale (Planned) | 20,000 | $62.47 | $1,249,400.00 | (< 1%) 7.2M to 7.18M | (52%) |
| 15-Apr-20 9:04 PM View: | Emergent BioSolutions, Inc. (EBS) | 15-Apr-20 | Market Sale (Planned) | 12,537 | $62.58 | $784,566.00 | (< 1%) 7.21M to 7.2M | (52%) |
| 15-Apr-20 9:04 PM View: | Emergent BioSolutions, Inc. (EBS) | 14-Apr-20 | Market Sale (Planned) | 6,261 | $62.99 | $394,380.00 | (< 1%) 7.22M to 7.21M | (51%) |
| 15-Apr-20 9:04 PM View: | Emergent BioSolutions, Inc. (EBS) | 13-Apr-20 | Market Sale (Planned) | 17,071 | $62.25 | $1,062,670.00 | (< 1%) 7.23M to 7.22M | (53%) |
| 10-Apr-20 7:13 PM View: | Emergent BioSolutions, Inc. (EBS) | 09-Apr-20 | Market Sale (Planned) | 23,716 | $61.83 | $1,466,360.00 | (< 1%) 7.26M to 7.23M | (54%) |
| 10-Apr-20 7:13 PM View: | Emergent BioSolutions, Inc. (EBS) | 08-Apr-20 | Market Sale (Planned) | 37,362 | $61.13 | $2,284,120.00 | (< 1%) 7.29M to 7.26M | (55%) |
| 08-Apr-20 9:17 PM View: | Emergent BioSolutions, Inc. (EBS) | 07-Apr-20 | Market Sale (Planned) | 14,336 | $60.76 | $871,055.00 | (< 1%) 7.31M to 7.29M | (56%) |
| 08-Apr-20 9:17 PM View: | Emergent BioSolutions, Inc. (EBS) | 06-Apr-20 | Market Sale (Planned) | 28,240 | $60.50 | $1,708,520.00 | (< 1%) 7.34M to 7.31M | (57%) |
| 28-Feb-20 8:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Feb-20 | Payment of Exercise | 3,854 | $58.42 | $225,151.00 | (< 1%) 7.35M to 7.35M | (63%) |
| 28-Feb-20 8:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Feb-20 | Option Exercise | 9,794 | -- | -- | < 1% 7.34M to 7.35M | |
| 28-Feb-20 8:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Feb-20 | Market Option Sale (Planned) | 2,604 | $56.97 | $148,350.00 | (< 1%) 7.35M to 7.34M | (67%) |
| 28-Feb-20 8:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Feb-20 | Market Sale (Planned) | 7,233 | $56.97 | $412,064.00 | (< 1%) 7.34M to 7.34M | (67%) |
| 28-Feb-20 8:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 26-Feb-20 | Payment of Exercise | 4,895 | $59.91 | $293,259.00 | (< 1%) 7.36M to 7.35M | (59%) |
| 28-Feb-20 8:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 26-Feb-20 | Option Exercise | 6,429 | -- | -- | < 1% 7.35M to 7.36M | |
| 28-Feb-20 8:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 26-Feb-20 | Market Option Sale (Planned) | 13,619 | $58.70 | $799,435.00 | (< 1%) 7.35M to 7.34M | (62%) |
| 27-Feb-20 9:22 PM View: | Emergent BioSolutions, Inc. (EBS) | 25-Feb-20 | Option Exercise | 6,010 | -- | -- | < 1% 7.35M to 7.35M | |
| 24-Feb-20 8:00 PM View: | Emergent BioSolutions, Inc. (EBS) | 21-Feb-20 | Option Exercise | 18,567 | $25.62 | $475,687.00 | < 1% 7.35M to 7.37M | |
| 24-Feb-20 8:00 PM View: | Emergent BioSolutions, Inc. (EBS) | 21-Feb-20 | Market Option Sale (Planned) | 18,567 | $64.90 | $1,205,000.00 | (< 1%) 7.37M to 7.35M | (46%) |
| 24-Feb-20 8:00 PM View: | Emergent BioSolutions, Inc. (EBS) | 20-Feb-20 | Option Exercise | 4,751 | $25.62 | $121,721.00 | < 1% 7.35M to 7.35M | |
| 24-Feb-20 8:00 PM View: | Emergent BioSolutions, Inc. (EBS) | 20-Feb-20 | Market Option Sale (Planned) | 4,751 | $64.90 | $308,340.00 | (< 1%) 7.35M to 7.35M | (46%) |
| 19-Feb-20 9:00 PM View: | Emergent BioSolutions, Inc. (EBS) | 18-Feb-20 | Option Exercise | 15,614 | $25.62 | $400,031.00 | < 1% 7.35M to 7.36M | |
| 19-Feb-20 9:00 PM View: | Emergent BioSolutions, Inc. (EBS) | 18-Feb-20 | Market Option Sale (Planned) | 15,614 | $63.90 | $997,735.00 | (< 1%) 7.36M to 7.35M | (49%) |
| 19-Feb-20 9:00 PM View: | Emergent BioSolutions, Inc. (EBS) | 14-Feb-20 | Option Exercise | 4,386 | $25.62 | $112,369.00 | < 1% 7.35M to 7.35M | |
| 19-Feb-20 9:00 PM View: | Emergent BioSolutions, Inc. (EBS) | 14-Feb-20 | Market Option Sale (Planned) | 4,386 | $63.90 | $280,265.00 | (< 1%) 7.35M to 7.35M | (49%) |
| 13-Feb-20 6:30 PM View: | Emergent BioSolutions, Inc. (EBS) | 12-Feb-20 | Option Exercise | 13,720 | $25.62 | $351,506.00 | < 1% 7.35M to 7.36M | |
| 13-Feb-20 6:30 PM View: | Emergent BioSolutions, Inc. (EBS) | 12-Feb-20 | Market Option Sale (Planned) | 13,720 | $62.90 | $862,988.00 | (< 1%) 7.36M to 7.35M | (51%) |
| 13-Feb-20 6:30 PM View: | Emergent BioSolutions, Inc. (EBS) | 11-Feb-20 | Option Exercise | 6,280 | $25.62 | $160,894.00 | < 1% 7.35M to 7.35M | |
| 13-Feb-20 6:30 PM View: | Emergent BioSolutions, Inc. (EBS) | 11-Feb-20 | Market Option Sale (Planned) | 6,280 | $62.90 | $395,012.00 | (< 1%) 7.35M to 7.35M | (51%) |
| 07-Feb-20 6:31 PM View: | Emergent BioSolutions, Inc. (EBS) | 06-Feb-20 | Market Sale | 11,684 | $61.90 | $723,240.00 | (< 1%) 7.3M to 7.29M | (54%) |
| 07-Feb-20 6:31 PM View: | Emergent BioSolutions, Inc. (EBS) | 05-Feb-20 | Market Sale (Planned) | 48,316 | $60.66 | $2,930,850.00 | (< 1%) 7.35M to 7.3M | (57%) |